Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study

BACKGROUND: In current clinical practice, controversy remains regarding the clinical benefits of prolonged dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients facing high risks of both ischemia and bleeding (“bi-risk”) following percutaneous coronary intervention (PCI). This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Kun, Qiu, Miaohan, Wei, Ningxin, Li, Jiayin, Yan, Chenghui, Li, Jing, Li, Yi, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514577/
https://www.ncbi.nlm.nih.gov/pubmed/37745130
http://dx.doi.org/10.3389/fcvm.2023.1201091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514577/
https://www.ncbi.nlm.nih.gov/pubmed/37745130
http://dx.doi.org/10.3389/fcvm.2023.1201091

Ejemplares similares